Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA064896-03
Application #
2107626
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1994-01-01
Project End
1998-12-31
Budget Start
1996-01-01
Budget End
1996-12-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Russo, J; Hu, Y F; Silva, I D et al. (2001) Cancer risk related to mammary gland structure and development. Microsc Res Tech 52:204-23
Russo, J; Russo, I H (2001) The pathway of neoplastic transformation of human breast epithelial cells. Radiat Res 155:151-154
Russo, I H; Russo, J (2000) Hormonal approach to breast cancer prevention. J Cell Biochem Suppl 34:6-Jan
Mgbonyebi, O P; Russo, J; Russo, I H (1999) Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells. Cancer Res 59:1903-10
Srivastava, P; Russo, J; Russo, I H (1999) Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin associated with increased expression of inhibin. Mol Carcinog 26:10-9
Russo, J; Russo, I H (1999) Cellular basis of breast cancer susceptibility. Oncol Res 11:169-78
Russo, I H; Russo, J (1998) Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 3:49-61
Srivastava, P; Russo, J; Mgbonyebi, O P et al. (1998) Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells. Anticancer Res 18:4003-10
Mgbonyebi, O P; Russo, J; Russo, I H (1998) Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 12:865-9
Mgbonyebi, O P; Russo, J; Russo, I H (1998) Roscovitine inhibits the proliferative activity of immortal and neoplastic human breast epithelial cells. Anticancer Res 18:751-5

Showing the most recent 10 out of 16 publications